The hypothalamic arcuate nucleus: A new site of cardiovascular action of angiotensin-(1-12) and angiotensin II

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 3, 2011, Pages

  Arakawa, Hideki ^a   Chitravanshi, Vineet C ^a   Sapru, Hreday N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Heart rate; Microinjection; N methyl D aspartic acid; Sympathetic nerve activity

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN (1-12); ANGIOTENSIN II; CAPTOPRIL; CHYMASE; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG; URETHAN; ZD 7155;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HEART RATE; HYPOTHALAMUS; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLANCHNIC NERVE; TACHYCARDIA; TREATMENT RESPONSE; VAGOTOMY; VAGUS NERVE; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; ANIMALS; ARCUATE NUCLEUS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHYMASES; MALE; MICROINJECTIONS; MUSCIMOL; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SPLANCHNIC NERVES; VAGUS NERVE;

EID: 79955069043     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01144.2010     Document Type: Article

References (50)

1. Arnold AC, Isa K, Shaltout HA, Nautiyal M, Ferrario Chappell MC CM, Diz DI. Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus. Am J Physiol Heart Circ Physiol 299: H763-H771, 2010.
2. Baltatu O, Nishimura H, Hoffmann S, Stoltenburg G, Haulica ID, Lippoldt A, Ganten D, Urata H. High levels of human chymase expression in the pineal and pituitary glands. Brain Res 752: 269-278, 1997.
3. Bell-Reuss E, Trevino DL, Gottschalk CW. Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 57: 1104-1107, 1976.
4. Blankley CJ, Hodges JC, Klutchko SR, Himmelsbach RJ, Chucholowski A, Connolly CJ, Neergaard SJ, Van Nieuwenhze MS, Sebastian A, Quin J, III, Essenberg AD, Cohen DM. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem 34: 3248-3260, 1991.
5. Brooks VL. Interactions between angiotensin II and the sympathetic nervous system in the long-term control of arterial pressure. Clin Exp Pharmacol Physiol 24: 83-90, 1997.
6. Cechetto DF, Saper CB. Neurochemical organization of the hypothalamic projection to spinal cord in the rat. J Comp Neurol 272: 579-604, 1988.
7. Chen QH, Toney GM. AT1-receptor blockade in the hypothalamic PVN reduces central hyperosmolality-induced renal sympathoexcitation. Am J Physiol Regul Integr Comp Physiol 281: R1844-R1853, 2001.
8. Chen QH, Toney GM. Responses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism. Am J Physiol Regul Integr Comp Physiol 285: R1231-R1239, 2003.
9. Ciriello J, McMurray JC, Babic T, de Oliveira CVR. Collateral axonal projections from hypothalamic hypocretin neurons to cardiovascular sites in nucleus ambiguus and nucleus tractus solitarius. Brain Res 991: 133-141, 2003.
10. Coote JH. The hypothalamus and cardiovascular regulation. In: Neural Mechanisms of Cardiovascular Regulation, edited by Dun NJ, Machado BH, Pilowsky PM. Boston, MA: Kluwer Academic, 2004, p. 117-146.
11. Dampney RA, Horiuchi J, Killinger S, Sheriff MJ, Tan PS, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 32: 419-425, 2005.
12. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 49: 1170-1177, 2007.
13. Donadio MV, Gomes CM, Sagae SC, Franci CR, Nselmo-Franci JA, Lucion AB, Sanvitto GL. Estradiol and progesterone modulation of angiotensin II receptors in the arcuate nucleus of ovariectomized and lactating rats. Brain Res 1083: 103-109, 2006.
14. Ferguson AV. Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89: 370-376, 2009.
15. Fontes MA, Martins Pinge MC, Naves V, Campagnole-Santos MJ, Lopes OU, Khosla MC, Santos RA. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res 750: 305-310, 1997.
16. Gruber K, Rae-Degueurce A, Wilkin LD, Mitchell LD, Johnson AK. Forebrain and brainstem afferents to the arcuate nucleus in the rat: potential pathways for the modulation of hypophyseal secretions. Neurosci Lett 75: 1-5, 1987.
17. Gyurko R, Wielbo D, Phillips MI. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept 49: 167-174, 1993.
18. He S, Gaca MD, McEuen AR, Walls AF. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 291: 517-523, 1999.
19. Healy DP, Printz MP. Distribution of immunoreactive angiotensin II, angiotensin I, angiotensinogen and renin in the central nervous system of intact and nephrectomized rats. Hypertension 6: I130-I136, 1984.
20. Hocht C, Gironacci MM, Mayer MA, Schuman M, Bertera FM, Taira CA. Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats. Regul Pept 146: 58-66, 2008.
21. Isa K, Garcia-Espinosa MA, Arnold AC, Pirro NT, Tommasi EN, Ganten D, Chappell MC, Ferrario CM, Diz DI. Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats. Am J Physiol Regul Integr Comp Physiol 297: R111-R115, 2009.
22. Johren O, Inagami T, Saavedra JM. Localization of AT2 angiotensin II receptor gene expression in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 37: 192-200, 1996.
23. Kang YM, Zhang ZH, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 295: H227-H236, 2008.
24. Kubo T, Yamaguchi H, Tsujimura M, Hagiwara Y, Fukumori R. An angiotensin system in the anterior hypothalamic area anterior is involved in the maintenance of hypertension in spontaneously hypertensive rats. Brain Res Bull 52: 291-296, 2000.
25. Li P, Tjen-ALooi SC, Guo ZL, Fu LW, Longhurst JC. Long-loop pathways in cardiovascular electroacupuncture responses. J Appl Physiol 106: 620-630, 2009.
26. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 92: 263-271, 2007.
27. Migdalof BH, Antonaccio MJ, McKinstry DN, Singhvi SM, Lan SJ, Egli P, Kripalani KJ. Captopril: pharmacology, metabolism and disposition. Drug Metab Rev 15: 841-869, 1984.
28. Morimoto S, Cassell MD, Beltz TG, Johnson AK, Davisson RL, Sigmund CD. Elevated blood pressure in transgenic mice with brainspecific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res 89: 365-372, 2001.
29. Munzberg H, Flier JS, Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145: 4880-4889, 2004.
30. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350: 1026-1031, 2006.
31. Nakamura T, Bhatt S, Sapru HN. Cardiovascular responses to hypothalamic arcuate nucleus stimulation in the rat: role of sympathetic and vagal efferents. Hypertension 54: 1369-1375, 2009.
32. Nakamura T, Kawabe K, Sapru HN. Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat. Am J Physiol Heart Circ Physiol 296: H325-H332, 2009.
33. Nicholson C. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333: 325-329, 1985.
34. Palkovits M. Stress-induced activation of neurons in the ventromedial arcuate nucleus: a blood-brain-CSF interface of the hypothalamus. Ann NY Acad Sci 1148: 57-63, 2008.
35. Patel D, Bohlke M, Phattanarudee S, Kabadi S, Maher TJ, Ally A. Cardiovascular responses and neurotransmitter changes during blockade of angiotensin II receptors within the ventrolateral medulla. Neurosci Res 60: 340-348, 2008.
36. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.). New York: Academic, 1986.
37. Prosser HC, Forster ME, Richards AM, Pemberton CJ. Cardiac chymase converts rat proangiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics. Cardiovasc Res 82: 40-50, 2009.
38. Rahmouni K, Morgan DA. Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension 49: 647-652, 2007.
39. Rosas-Arellano MP, Solano-Flores LP, Ciriello J. Glutamate stimulation of arcuate nucleus inhibits responses of subfornical organ neurons to plasma hypernatremia and angiotensin II. Neurosci Lett 198: 201-204, 1995.
40. Rosas-Arellano MP, Solano-Flores LP, Ciriello J. Arcuate nucleus inputs onto subfornical organ neurons that respond to plasma hypernatremia and angiotensin II. Brain Res 707: 308-313, 1996.
41. Sapru HN, Gonzalez ER, Krieger AJ. Greater splanchnic nerve activity in the rat. Brain Res Bull 8: 267-272, 1982.
42. Sheriff MJ, Fontes MAP, Killinger S, Horiuchi J, Dampney RAL. Blockade of AT1 receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions. Am J Physiol Regul Integr Comp Physiol 290: R733-R740, 2006.
43. Sim LJ, Joseph SA. Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat 4: 97-109, 1991.
44. Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med 86: 663-671, 2008.
45. Wang HJ, Zhang F, Zhang Y, Gao XY, Wang W, Zhu GQ. AT1 receptor in paraventricular nucleus mediates the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Auton Neurosci 121: 56-63, 2005.
46. Yongue G, Angulo JA, McEwen BS, Myers MM. Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats. Hypertension 17: 485-491, 1991.
47. Yoshimatsu H, Egawa M, Bray GA. Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate. Brain Res 601: 121-128, 1993.
48. Zheng H, Li Y, Wang W, Patel KP. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol 297: R1364-R1374, 2009.
49. Zhu GQ, Lie G, Patel KM, Zucker IH, Wang W. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol 97: 1746-1754, 2004.
50. Zini S, Masdehors P, Lenkei Z, Fournie-Zaluski MC, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 78: 1187-1193, 1997.